[Therapeutic indications in spasticity symptoms of multiple sclerosis].
Spasticity is reported in 90 p. 100 of multiple sclerosis patients causing pain, spasms, loss of function and difficulties in nursing care. A variety of oral and parenteral medications are available. Review of comparative efficacy and tolerability of anti-spastic agents is performed in order to guide rational prescribing.
Lebrun
C
C
Service de Neurologie, Hôpital Pasteur, 30 Voie Romaine, BP69, 06002 Nice.
D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000188:drug therapy*; D009128:Muscle Spasticity / Q000175:diagnosis / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D009465:Neuromuscular Agents
Indications thérapeutiques à visée symptomatique de la spasticité dans la sclérose en plaques.